From: Atypical presentations of coronavirus disease 2019 (COVID-19) from onset to readmission
Features | NRP patients (n=72) | RP patients(n=7) | P-value |
---|---|---|---|
Sex | |||
Male# | 40(55. 6%) | 4(57.1%) | 0.751a |
Female# | 32(44.4%) | 3(42.9%) | |
Age | 41.9±13.8 | 41.0±19.8 | 0.880b |
Course of disease | 2.50±2.58 | 2.43±2.82 | 0.950b |
Clinical types | 0.604c | ||
Mild# | 10(13.9%) | 1(14.3%) | |
Moderate# | 55(76.4%) | 6(85.7%) | |
Severe# | 7(9.70%) | 0(0.0%) | |
Symptoms | 1.00a | ||
Symptomatic# | 63(87.5%) | 6(85.7%) | |
Asymptomatic# | 9(12.5%) | 1(14.3%) | |
Hospitalization days | 15.8±6.86 | 18.3±5.35 | 0.357b |
Days of last RNA negative-conversion | 12.4±6.58 | 15.3±5.38 | 0.270b |
Days of last RNA negative-conversion category | 0.096c | ||
< 7 days# | 10(13.9%) | 0(0.0%) | |
7 days to 14 days# | 40(55.6%) | 3(42.8%) | |
14 days to 21 days# | 19(26.4%) | 3(42.9%) | |
> 21 days# | 3(4.1%) | 1(14.3%) | |
WBC count (× 109/L) | 5.28±2.30 | 7.07±3.29 | 0.062b |
Lymphocyte count | 1.32±0.86 | 1.22±0.38 | 0.763b |
Lymphocyte rate (%) | 25.6±11.4 | 21.0±10.4 | 0.313b |
Neutrophil count(×109/L) | 3.48±2.01 | 5.14±3.23 | 0.228b |
Neutrophil rate (%) | 64.4±14.3 | 63.9±17.6 | 0.931b |